You just read:

Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer

News provided by

Taiho Oncology, Inc.

May 09, 2018, 02:00 ET